Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

43 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Two-Decade Trends in the Prevalence of Atherosclerotic Risk Factors, Coronary Plaque Morphology, and Outcomes in Adults Aged ≤45 Years Undergoing Percutaneous Coronary Intervention.
Poddar KL, Modi DK, Wayangankar S, Thakkar B, Krishnaswamy A, Kumari M, Bdair H, Sud K, Parashar A, Raza MQ, Faruqui R, Agarwal S, Banerjee K, Tuzcu EM, Kapadia SR. Poddar KL, et al. Among authors: wayangankar s. Am J Cardiol. 2016 Oct 1;118(7):939-43. doi: 10.1016/j.amjcard.2016.06.055. Epub 2016 Jul 18. Am J Cardiol. 2016. PMID: 27553096
Length of Stay After Transfemoral Transcatheter Aortic Valve Replacement: An Analysis of the Society of Thoracic Surgeons/American College of Cardiology Transcatheter Valve Therapy Registry.
Wayangankar SA, Elgendy IY, Xiang Q, Jneid H, Vemulapalli S, Khachatryan T, Pham D, Hilliard AA, Kapadia SR. Wayangankar SA, et al. JACC Cardiovasc Interv. 2019 Mar 11;12(5):422-430. doi: 10.1016/j.jcin.2018.11.015. JACC Cardiovasc Interv. 2019. PMID: 30846079 Free article.
Temporal Trends and Outcomes of Patients Undergoing Percutaneous Coronary Interventions for Cardiogenic Shock in the Setting of Acute Myocardial Infarction: A Report From the CathPCI Registry.
Wayangankar SA, Bangalore S, McCoy LA, Jneid H, Latif F, Karrowni W, Charitakis K, Feldman DN, Dakik HA, Mauri L, Peterson ED, Messenger J, Roe M, Mukherjee D, Klein A. Wayangankar SA, et al. JACC Cardiovasc Interv. 2016 Feb 22;9(4):341-351. doi: 10.1016/j.jcin.2015.10.039. Epub 2016 Jan 20. JACC Cardiovasc Interv. 2016. PMID: 26803418 Free article.
Bioresorbable Stents: Is This Where We Are Headed?
Wayangankar SA, Ellis SG. Wayangankar SA, et al. Prog Cardiovasc Dis. 2015 Nov-Dec;58(3):342-55. doi: 10.1016/j.pcad.2015.08.011. Epub 2015 Aug 28. Prog Cardiovasc Dis. 2015. PMID: 26319497 Review.
Drug-Eluting Balloons Versus Everolimus-Eluting Stents for In-Stent Restenosis: A Meta-Analysis of Randomized Trials.
Elgendy IY, Mahmoud AN, Elgendy AY, Mojadidi MK, Elbadawi A, Eshtehardi P, Pérez-Vizcayno MJ, Wayangankar SA, Jneid H, David Anderson R, Alfonso F. Elgendy IY, et al. Among authors: wayangankar sa. Cardiovasc Revasc Med. 2019 Jul;20(7):612-618. doi: 10.1016/j.carrev.2018.08.010. Epub 2018 Aug 16. Cardiovasc Revasc Med. 2019. PMID: 30126824
43 results